Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Lymphoma, B-Cell
  • Radioimmunotherapy

abstract

  • Re-treatment with I-131 tositumomab following a previous response can produce second responses that can be durable.

publication date

  • December 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.01.0892

PubMed ID

  • 16204016

Additional Document Info

start page

  • 7985

end page

  • 93

volume

  • 23

number

  • 31